KEVIN GAREY to Dysbiosis
This is a "connection" page, showing publications KEVIN GAREY has written about Dysbiosis.
Connection Strength
0.247
-
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies. Gut Microbes. 2023 Jan-Dec; 15(1):2223345.
Score: 0.193
-
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response. Clin Infect Dis. 2024 06 14; 78(6):1462-1472.
Score: 0.053